SEC Form 4 · accession 0001144204-16-128481
ENvue Medical, Inc. · FEED
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher M Fashek
Director
Period of report
Oct 14, 2016
Accepted (ET)
Oct 18, 2016 · 3:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326706
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1 | $5.50 | Oct 14, 2016 | A | 91,679 | A | — | Oct 14, 2026 | Common Stock | 91,679 | 91,679 | D |
Explanation of responses
- F1On October 14, 2016, the reporting person was granted an option to purchase shares of common stock outside the NanoVibronix, Inc. 2014 Long-Term Incentive Plan. The option vests in four installments as follows: (i) 1/4 of the total shares (rounded down for fractional shares) on the first anniversary of the grant date, (ii) 1/4 of the total shares (rounded down for fractional shares) on the second anniversary of the grant date, (iii) 1/4 of the total shares (rounded down for fractional shares) on the third anniversary of the grant date, and (iv) the remaining shares on the fourth anniversary of the grant date. Vesting is subject to the reporting person's continued service to the Issuer.